Annexon is based out of Brisbane. Annexon, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. The firm last filed a Form D notice of exempt offering of securities on 2022-07-22. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Annexon, Inc.1400 SIERRA POINT PARKWAY
BRISBANE CA 94005
Business Phone: (650)-822-5500
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS